Skip to main content

stock

AMGN · AMGEN INC

What AMGEN INC reports to the SEC, read from its filings.

Open in the app

Price

The live AMGN price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on AMGN.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
540,632,005 as of 2026-07-30 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
30.0%
Net
23.0%

Returns

ROE
74.8%
ROA
9.1%

Health

Current ratio
1.4x
Debt/equity
4.9x

Deep value

NCAV
—
NCAV per share
—
Price/NCAV
Locked
NNWC
—
NNWC per share
—
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30$10.05B—$3.51B$2.38B
10-Q filed 2026-08-05
2026-03-31$8.62B—$2.67B$1.82B
10-Q filed 2026-05-01
2025-12-31$9.87B—$2.72B$1.33B
DEF 14A filed 2026-04-07
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30$9.56B—$2.53B$3.22B
10-Q filed 2025-11-05
2025-06-30$9.18B—$2.66B$1.43B
10-Q filed 2026-08-05
2025-03-31$8.15B—$1.18B$1.73B
10-Q filed 2026-05-01
2024-12-31$9.09B—$2.31B$627.00M
DEF 14A filed 2026-04-07
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$8.50B—$2.05B$2.83B
10-Q filed 2025-11-05
Assets
$95.64B
Equity
$11.69B

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$36.75B$9.08B$7.71B$8.10B
2024-12-31$33.42B$7.26B$4.09B$10.39B
2023-12-31$28.19B$7.90B$6.72B$7.36B
2022-12-31$26.32B$9.57B$6.55B$8.79B
2021-12-31$25.98B$7.64B$5.89B$8.38B
2020-12-31$25.42B$9.14B$7.26B$9.89B
2019-12-31$23.36B$9.67B$7.84B$8.53B
2018-12-31$23.75B$10.26B$8.39B$10.56B
2017-12-31$22.85B$9.97B$1.98B$10.51B
2016-12-31$22.99B$9.79B$7.72B$9.62B

Company filings

Insiders, politicians and funds

Insider trades, last 90 days

Politician trades, last 90 days

Funds

All funds

News

Stories that named AMGN, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about AMGN.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about AMGN.

nakagai

Signals on AMGN come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the AMGN board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.